Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05NHT
|
|||
| Former ID |
DIB005590
|
|||
| Drug Name |
BP-C1
|
|||
| Indication | Breast cancer [ICD-11: 2C60-2C65] | Phase 1 | [1] | |
| Company |
Meabco A/S
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01861509) BP-C1 in Metastatic Breast Cancer Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.